 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Tilton John
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2017-11-01 Sale | 2017-11-02 5:55 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 30,000 | $29.25 | $877,586 | 0 (Indirect Direct) | View |
| 2019-01-10 Sale | 2019-01-14 5:50 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,500 | $37.67 | $395,535 | 0 (Indirect Direct) | View |
| 2019-03-12 Sale | 2019-03-14 5:51 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,000 | $50.11 | $501,100 | 0 (Indirect Direct) | View |
| 2020-06-10 Sale | 2020-06-12 5:19 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 52,000 | $67.38 | $3,504,000 | 770 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2017-05-09 Conversion | 2017-05-11 5:33 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 1,614 | $0 | 0 (Indirect) | View |
| 2017-05-09 Conversion | 2017-05-11 5:33 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 1,614 | $0 | 0 (Indirect) | View |
| 2017-11-01 Exercise | 2017-11-02 5:55 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 30,000 | $9.29 | 0 (Direct) | View |
| 2017-11-01 Exercise | 2017-11-02 5:55 pm | N/A 2027-01-30 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 30,000 | $9.29 | 0 (Direct) | View |
| 2017-12-07 Option Award | 2017-12-11 5:37 pm | N/A 2027-12-06 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 21,740 | $20.79 | 21,740 (Direct) | View |
| 2019-01-10 Exercise | 2019-01-14 5:50 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,500 | $9.29 | 0 (Direct) | View |
| 2019-01-10 Exercise | 2019-01-14 5:50 pm | N/A 2026-12-14 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,500 | $9.29 | 0 (Direct) | View |
| 2019-03-12 Exercise | 2019-03-14 5:51 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,000 | $9.29 | 0 (Direct) | View |
| 2019-03-12 Exercise | 2019-03-14 5:51 pm | N/A 2027-01-30 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,000 | $9.29 | 0 (Direct) | View |
| 2019-11-25 Option Award | 2019-11-27 9:31 pm | N/A 2029-11-24 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John CCO-Rare & Neurologic Disorder | 10,000 | $57.4 | 5,000 (Direct) | View |
| 2019-11-25 Option Award | 2019-11-27 9:31 pm | N/A 2022-11-24 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John CCO-Rare & Neurologic Disorder | 5,000 | $0 | 5,000 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 9:41 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John CCO-Rare & Neurologic Disorder | 1,250 | $0 | 3,750 (Direct) | View |
| 2019-12-18 Tax Withholding | 2019-12-20 9:41 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John CCO-Rare & Neurologic Disorder | 480 | $52.13 | 3,750 (Direct) | View |
| 2019-12-18 Exercise | 2019-12-20 9:41 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John CCO-Rare & Neurologic Disorder | 1,250 | $0 | 3,750 (Direct) | View |
| 2020-06-10 Exercise | 2020-06-12 5:19 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 52,000 | $9.29 | 770 (Direct) | View |
| 2020-06-10 Exercise | 2020-06-12 5:19 pm | N/A 2027-01-30 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 52,000 | $9.29 | 770 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 9:48 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 1,250 | $0 | 2,500 (Direct) | View |
| 2020-11-25 Tax Withholding | 2020-11-27 9:48 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 480 | $90.14 | 2,500 (Direct) | View |
| 2020-11-25 Exercise | 2020-11-27 9:48 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 1,250 | $0 | 2,500 (Direct) | View |
| 2021-01-06 Exercise | 2021-01-08 8:49 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 1,250 | $0 | 3,750 (Direct) | View |
| 2021-01-06 Tax Withholding | 2021-01-08 8:49 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 492 | $83.38 | 3,750 (Direct) | View |
| 2021-01-06 Option Award | 2021-01-08 8:49 pm | N/A 2031-01-06 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,000 | $83.38 | 3,750 (Direct) | View |
| 2021-01-06 Option Award | 2021-01-08 8:49 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 5,000 | $0 | 3,750 (Direct) | View |
| 2021-01-06 Exercise | 2021-01-08 8:49 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 1,250 | $0 | 3,750 (Direct) | View |